Description

Rovamicin (Spiramycin) Coated Tablets 1500000 IU №16

Ingredients:

Each coated tablet contains 1500000 IU of Spiramycin as the active ingredient. Inactive ingredients include microcrystalline cellulose, maize starch, talc, and magnesium stearate.

Dosage:

The recommended dosage for adults is one tablet three times a day. Dosage may vary based on the severity of the infection and should be determined by a healthcare professional.

Indications:

Rovamicin tablets are indicated for the treatment of bacterial infections caused by susceptible strains. These may include respiratory tract infections, skin and soft tissue infections, and sexually transmitted diseases.

Contraindications:

Do not use Rovamicin tablets if you are allergic to Spiramycin or any other ingredients in the formulation. It is important to consult with a healthcare provider before starting this medication.

Directions:

Take Rovamicin tablets as prescribed by your healthcare provider. The tablets should be swallowed whole with a full glass of water. Do not crush or chew the tablets.

Scientific Evidence:

Spiramycin, the active ingredient in Rovamicin tablets, is a macrolide antibiotic with broad-spectrum antibacterial activity. Studies have shown its efficacy in treating various bacterial infections, including those resistant to other antibiotics. Research published in the Journal of Antimicrobial Chemotherapy demonstrated the effectiveness of Spiramycin in treating respiratory tract infections.

Additional Information:

Rovamicin tablets have been well-tolerated in clinical trials, with minimal side effects reported. It is important to complete the full course of treatment as prescribed by your healthcare provider to ensure the infection is fully eradicated. If you experience any severe or persistent side effects, contact your doctor immediately.

Pharmacological Effects: Spiramycin works by inhibiting bacterial protein synthesis, leading to the suppression of bacterial growth and replication. It is particularly effective against gram-positive bacteria and some gram-negative bacteria.

Comparative Effectiveness: Compared to other macrolide antibiotics, Spiramycin has shown comparable efficacy in the treatment of various bacterial infections. Its unique pharmacokinetic profile and low resistance development make it a valuable option in clinical practice.